$HSGX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ocugen, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Ocugen, Inc.. Get notifications about new insider transactions in Ocugen, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 03 2018 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Operating Off ... | Option Exercise | A | 0.57 | 25,000 | 14,200 | 25,000 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Operating Off ... | Option Exercise | D | 2.56 | 25,000 | 64,000 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Operating Off ... | Option Exercise | A | 0.57 | 50,000 | 28,400 | 50,000 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Operating Off ... | Option Exercise | D | 6.11 | 50,000 | 305,500 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Operating Off ... | Option Exercise | A | 0.57 | 49,100 | 27,889 | 49,100 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Operating Off ... | Option Exercise | D | 9.96 | 49,100 | 489,036 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Operating Off ... | Option Exercise | A | 0.57 | 27,767 | 15,772 | 27,767 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Operating Off ... | Option Exercise | D | 7.13 | 27,767 | 197,979 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Haut Donald | Chief Business Offi ... | Option Exercise | A | 0.57 | 105,000 | 59,640 | 105,000 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Haut Donald | Chief Business Offi ... | Option Exercise | D | 2.63 | 105,000 | 276,150 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Haut Donald | Chief Business Offi ... | Option Exercise | A | 0.57 | 195,000 | 110,760 | 195,000 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Haut Donald | Chief Business Offi ... | Option Exercise | D | 1.67 | 195,000 | 325,650 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | D | 6.37 | 30,000 | 191,100 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 0.57 | 130,000 | 73,840 | 130,000 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | D | 2.63 | 130,000 | 341,900 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 0.57 | 50,000 | 28,400 | 50,000 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | D | 1.72 | 50,000 | 86,000 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 0.57 | 28,000 | 15,904 | 28,000 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | D | 2.56 | 28,000 | 71,680 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 0.57 | 110,000 | 62,480 | 110,000 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | D | 6.37 | 110,000 | 700,700 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Gridley Adam | President and CEO | Option Exercise | D | 9.96 | 60,000 | 597,600 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Gridley Adam | President and CEO | Option Exercise | A | 0.57 | 300,000 | 170,400 | 300,000 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Gridley Adam | President and CEO | Option Exercise | D | 2.63 | 300,000 | 789,000 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Gridley Adam | President and CEO | Option Exercise | A | 0.57 | 175,000 | 99,400 | 175,000 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Gridley Adam | President and CEO | Option Exercise | D | 1.72 | 175,000 | 301,000 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Gridley Adam | President and CEO | Option Exercise | A | 0.57 | 175,000 | 99,400 | 175,000 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Gridley Adam | President and CEO | Option Exercise | D | 1.58 | 175,000 | 276,500 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Gridley Adam | President and CEO | Option Exercise | A | 0.57 | 104,000 | 59,072 | 104,000 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Gridley Adam | President and CEO | Option Exercise | D | 9.96 | 104,000 | 1,035,840 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Gridley Adam | President and CEO | Option Exercise | A | 0.57 | 38,220 | 21,709 | 38,220 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Gridley Adam | President and CEO | Option Exercise | D | 8.97 | 38,220 | 342,833 | 0 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Gridley Adam | President and CEO | Option Exercise | A | 0.57 | 197,435 | 112,143 | 197,435 | |
Oct 03 2018 | HSGX | HISTOGENICS CORP | Gridley Adam | President and CEO | Option Exercise | D | 7.99 | 197,435 | 1,577,506 | 0 | |
Aug 01 2018 | HSGX | HISTOGENICS CORP | Kelley Lynne E | Chief Medical Offic ... | Option Exercise | A | 2.21 | 200,000 | 442,000 | 200,000 | |
Jun 19 2018 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | A | 2.97 | 25,000 | 74,250 | 25,000 | |
Jun 19 2018 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Option Exercise | A | 2.97 | 25,000 | 74,250 | 25,000 | |
Jun 19 2018 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 2.97 | 25,000 | 74,250 | 25,000 | |
Jun 19 2018 | HSGX | HISTOGENICS CORP | Kong Garheng | Director | Option Exercise | A | 2.97 | 25,000 | 74,250 | 25,000 | |
Jun 19 2018 | HSGX | HISTOGENICS CORP | Baltzell Joshua J | Director | Option Exercise | A | 2.97 | 25,000 | 74,250 | 25,000 | |
Jun 19 2018 | HSGX | HISTOGENICS CORP | JOHNSON JOHN | Director | Option Exercise | A | 2.97 | 25,000 | 74,250 | 25,000 | |
May 18 2018 | HSGX | HISTOGENICS CORP | Gridley Adam | President and CEO | Buy | P | 2.15 | 2,000 | 4,300 | 7,000 | 5 K to 7 K (+40.00 %) |
Apr 18 2018 | HSGX | HISTOGENICS CORP | Washer Susan B. | Director | Option Exercise | A | 2.84 | 25,000 | 71,000 | 25,000 | |
Feb 21 2018 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Technology Of ... | Option Exercise | A | 2.63 | 115,000 | 302,450 | 115,000 | |
Feb 21 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 2.63 | 130,000 | 341,900 | 130,000 | |
Feb 21 2018 | HSGX | HISTOGENICS CORP | Haut Donald | Chief Business Offi ... | Option Exercise | A | 2.63 | 105,000 | 276,150 | 105,000 | |
Feb 21 2018 | HSGX | HISTOGENICS CORP | Gridley Adam | See Remarks | Option Exercise | A | 2.63 | 300,000 | 789,000 | 300,000 | |
Oct 12 2017 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | EVP and COO | Option Exercise | A | 2.12 | 50,000 | 106,000 | 50,000 | |
Aug 17 2017 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | P | 1.81 | 3,000 | 5,439 | 14,000 | 11 K to 14 K (+27.27 %) |
Jun 14 2017 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Option Exercise | A | 1.70 | 25,000 | 42,500 | 25,000 | |
Jun 14 2017 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 1.70 | 25,000 | 42,500 | 25,000 | |
Jun 14 2017 | HSGX | HISTOGENICS CORP | JOHNSON JOHN | Director | Option Exercise | A | 1.70 | 25,000 | 42,500 | 25,000 | |
Jun 14 2017 | HSGX | HISTOGENICS CORP | Baltzell Joshua J | Director | Option Exercise | A | 1.70 | 25,000 | 42,500 | 25,000 | |
Jun 14 2017 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | A | 1.70 | 25,000 | 42,500 | 25,000 | |
Jun 14 2017 | HSGX | HISTOGENICS CORP | Kong Garheng | Director | Option Exercise | A | 1.70 | 25,000 | 42,500 | 25,000 | |
Jun 06 2017 | HSGX | HISTOGENICS CORP | Haut Donald | Chief Business Offi ... | Option Exercise | A | 1.67 | 195,000 | 325,650 | 195,000 | |
May 17 2017 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | P | 1.68 | 3,000 | 5,040 | 11,000 | 8 K to 11 K (+37.50 %) |
Feb 15 2017 | HSGX | HISTOGENICS CORP | Matthews Gloria | Chief Medical Offic ... | Option Exercise | A | 1.72 | 70,000 | 120,400 | 70,000 | |
Feb 15 2017 | HSGX | HISTOGENICS CORP | Gridley Adam | See Remarks | Option Exercise | A | 1.72 | 175,000 | 301,000 | 175,000 | |
Feb 15 2017 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 1.72 | 50,000 | 86,000 | 50,000 | |
Feb 15 2017 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Technology Of ... | Option Exercise | A | 1.72 | 75,000 | 129,000 | 75,000 | |
Jan 27 2017 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Option Exercise | C | 0.00 | 2,507 | 0 | 0 | |
Jan 27 2017 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Buy | C | 0.00 | 1,114,043 | 0 | 2,775,538 | 1.7 M to 2.8 M (+67.05 %) |
Dec 19 2016 | HSGX | HISTOGENICS CORP | Gridley Adam | See Remarks | Option Exercise | A | 1.58 | 175,000 | 276,500 | 175,000 | |
Dec 19 2016 | HSGX | HISTOGENICS CORP | Baltzell Joshua J | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
Dec 19 2016 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
Dec 19 2016 | HSGX | HISTOGENICS CORP | JOHNSON JOHN | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
Dec 19 2016 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
Dec 19 2016 | HSGX | HISTOGENICS CORP | Kong Garheng | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
Dec 19 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
Dec 15 2016 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | P | 1.65 | 3,000 | 4,950 | 8,000 | 5 K to 8 K (+60.00 %) |
Dec 15 2016 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | P | 1.92 | 5,000 | 9,600 | 5,000 | 0 to 5 K |
Dec 06 2016 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Option Exercise | C | 0.00 | 2,243 | 0 | 0 | |
Dec 06 2016 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Buy | C | 0.00 | 996,779 | 0 | 3,072,110 | 2.1 M to 3.1 M (+48.03 %) |
Dec 05 2016 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Option Exercise | C | 0.00 | 2,243 | 0 | 0 | |
Dec 05 2016 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Buy | C | 0.00 | 996,779 | 0 | 3,072,110 | 2.1 M to 3.1 M (+48.03 %) |
Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | C | 0.00 | 200 | 0 | 0 | |
Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | C | 0.00 | 60 | 0 | 0 | |
Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | C | 0.00 | 60 | 0 | 0 | |
Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | C | 0.00 | 88,998 | 0 | 228,196 | 139.2 K to 228.2 K (+63.94 %) |
Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | C | 0.00 | 26,699 | 0 | 139,198 | 112.5 K to 139.2 K (+23.73 %) |
Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | C | 0.00 | 26,699 | 0 | 112,499 | 85.8 K to 112.5 K (+31.12 %) |
Dec 02 2016 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Buy | P | 1.95 | 5,000 | 9,731 | 5,000 | 0 to 5 K |
Dec 02 2016 | HSGX | HISTOGENICS CORP | Gridley Adam | President and CEO | Buy | P | 2.01 | 5,000 | 10,040 | 5,000 | 0 to 5 K |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 2.25 | 111,111 | 250,000 | 177,777 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 2.25 | 33,333 | 74,999 | 66,666 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 2.25 | 33,333 | 74,999 | 33,333 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 0.00 | 200 | 0 | 320 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 0.00 | 60 | 0 | 120 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 0.00 | 60 | 0 | 60 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Grant | A | 2.25 | 22,113 | 49,754 | 85,800 | 63.7 K to 85.8 K (+34.72 %) |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Grant | A | 2.25 | 6,634 | 14,927 | 63,687 | 57.1 K to 63.7 K (+11.63 %) |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Grant | A | 2.25 | 6,634 | 14,927 | 57,053 | 50.4 K to 57.1 K (+13.16 %) |
Oct 03 2016 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Option Exercise | A | 2.25 | 1,244,444 | 2,799,999 | 0 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Option Exercise | A | 0.00 | 2,243 | 0 | 0 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Grant | A | 2.25 | 247,665 | 557,246 | 2,075,331 | 1.8 M to 2.1 M (+13.55 %) |
Oct 03 2016 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Option Exercise | A | 2.25 | 1,244,444 | 2,799,999 | 0 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Option Exercise | A | 0.00 | 2,243 | 0 | 0 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Grant | A | 2.25 | 247,665 | 557,246 | 2,075,331 | 1.8 M to 2.1 M (+13.55 %) |
Oct 03 2016 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Option Exercise | P | 2.25 | 1,390,844 | 3,129,399 | 1,390,844 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Option Exercise | P | 0.00 | 2,507 | 0 | 2,507 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Buy | P | 2.25 | 276,801 | 622,802 | 1,661,495 | 1.4 M to 1.7 M (+19.99 %) |
Mar 01 2016 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 2.56 | 28,000 | 71,680 | 28,000 | |
Mar 01 2016 | HSGX | HISTOGENICS CORP | Matthews Gloria | Chief Medical Offic ... | Option Exercise | A | 2.56 | 39,000 | 99,840 | 39,000 | |
Mar 01 2016 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Technology Of ... | Option Exercise | A | 2.56 | 25,000 | 64,000 | 25,000 | |
Jul 31 2015 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | Chief Technology Of ... | Option Exercise | A | 6.11 | 50,000 | 305,500 | 50,000 | |
Jul 31 2015 | HSGX | HISTOGENICS CORP | Matthews Gloria | Chief Medical Offic ... | Option Exercise | A | 6.11 | 30,000 | 183,300 | 30,000 | |
Jul 31 2015 | HSGX | HISTOGENICS CORP | Matthews Gloria | Chief Medical Offic ... | Option Exercise | A | 6.11 | 120,000 | 733,200 | 120,000 | |
Jul 06 2015 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 6.39 | 30,000 | 191,700 | 30,000 | |
Jul 06 2015 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 6.39 | 110,000 | 702,900 | 110,000 | |
Jun 26 2015 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | A | 6.86 | 6,800 | 46,648 | 6,800 | |
Jun 26 2015 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Option Exercise | A | 6.86 | 20,000 | 137,200 | 20,000 | |
Jun 26 2015 | HSGX | HISTOGENICS CORP | JOHNSON JOHN | Director | Option Exercise | A | 6.86 | 10,475 | 71,859 | 10,475 | |
Jun 26 2015 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 6.86 | 20,000 | 137,200 | 20,000 | |
Jun 26 2015 | HSGX | HISTOGENICS CORP | Baltzell Joshua J | Director | Option Exercise | A | 6.86 | 20,000 | 137,200 | 20,000 | |
Jun 26 2015 | HSGX | HISTOGENICS CORP | Kong Garheng | Director | Option Exercise | A | 6.86 | 20,000 | 137,200 | 20,000 | |
Jun 03 2015 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Sell | J | 0.00 | 89,441 | 0 | 1,827,666 | 1.9 M to 1.8 M (-4.67 %) |
Jun 03 2015 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Sell | J | 0.00 | 89,441 | 0 | 1,827,666 | 1.9 M to 1.8 M (-4.67 %) |
Feb 27 2015 | HSGX | HISTOGENICS CORP | Gridley Adam | See Remarks | Option Exercise | A | 9.96 | 60,000 | 597,600 | 60,000 | |
Feb 27 2015 | HSGX | HISTOGENICS CORP | Gridley Adam | See Remarks | Option Exercise | A | 9.96 | 104,000 | 1,035,840 | 104,000 | |
Feb 27 2015 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | SVP of Technical Op ... | Option Exercise | A | 9.96 | 30,000 | 298,800 | 30,000 | |
Feb 27 2015 | HSGX | HISTOGENICS CORP | Kennedy Stephen Richard | SVP of Technical Op ... | Option Exercise | A | 9.96 | 49,100 | 489,036 | 49,100 | |
Feb 27 2015 | HSGX | HISTOGENICS CORP | McArdle Kevin | Chief Financial Off ... | Option Exercise | A | 9.96 | 30,000 | 298,800 | 30,000 | |
Feb 27 2015 | HSGX | HISTOGENICS CORP | McArdle Kevin | Chief Financial Off ... | Option Exercise | A | 9.96 | 27,000 | 268,920 | 27,000 | |
Feb 02 2015 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | A | 8.30 | 13,200 | 109,560 | 13,200 | |
Dec 10 2014 | HSGX | HISTOGENICS CORP | Sofinnova Venture Partners VII ... | 10% Owner | Option Exercise | X | 0.76 | 14,569 | 11,072 | 0 | |
Dec 10 2014 | HSGX | HISTOGENICS CORP | Sofinnova Venture Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 611,738 | 0 | 0 | |
Dec 10 2014 | HSGX | HISTOGENICS CORP | Sofinnova Venture Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 960,345 | 0 | 0 | |
Dec 10 2014 | HSGX | HISTOGENICS CORP | Sofinnova Venture Partners VII ... | 10% Owner | Sell | J | 0.00 | 8,808 | 0 | 2,077,040 | 2.1 M to 2.1 M (-0.42 %) |
Dec 10 2014 | HSGX | HISTOGENICS CORP | Sofinnova Venture Partners VII ... | 10% Owner | Buy | P | 11.00 | 500,198 | 5,502,178 | 2,085,848 | 1.6 M to 2.1 M (+31.55 %) |
Dec 10 2014 | HSGX | HISTOGENICS CORP | Sofinnova Venture Partners VII ... | 10% Owner | Sell | S | 11.00 | 1,002 | 11,022 | 1,585,650 | 1.6 M to 1.6 M (-0.06 %) |
Dec 10 2014 | HSGX | HISTOGENICS CORP | Sofinnova Venture Partners VII ... | 10% Owner | Buy | X | 0.76 | 14,569 | 11,072 | 1,586,652 | 1.6 M to 1.6 M (+0.93 %) |
Dec 10 2014 | HSGX | HISTOGENICS CORP | Sofinnova Venture Partners VII ... | 10% Owner | Buy | C | 0.00 | 611,738 | 0 | 1,572,083 | 960.3 K to 1.6 M (+63.70 %) |
Dec 10 2014 | HSGX | HISTOGENICS CORP | Sofinnova Venture Partners VII ... | 10% Owner | Buy | C | 0.00 | 960,345 | 0 | 960,345 | 0 to 960.3 K |
Dec 08 2014 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Option Exercise | X | 0.76 | 9,713 | 7,382 | 0 | |
Dec 08 2014 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Option Exercise | C | 0.00 | 407,825 | 0 | 0 | |
Dec 08 2014 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Option Exercise | C | 0.00 | 640,230 | 0 | 0 | |
Dec 08 2014 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Sell | J | 0.00 | 5,872 | 0 | 1,384,694 | 1.4 M to 1.4 M (-0.42 %) |
Dec 08 2014 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Buy | P | 11.00 | 333,466 | 3,668,126 | 1,390,566 | 1.1 M to 1.4 M (+31.55 %) |
Dec 08 2014 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Sell | S | 11.00 | 668 | 7,348 | 1,057,100 | 1.1 M to 1.1 M (-0.06 %) |
Dec 08 2014 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Buy | X | 0.76 | 9,713 | 7,382 | 1,057,768 | 1 M to 1.1 M (+0.93 %) |
Dec 08 2014 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Buy | C | 0.00 | 407,825 | 0 | 1,048,055 | 640.2 K to 1 M (+63.70 %) |
Dec 08 2014 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Buy | C | 0.00 | 640,230 | 0 | 640,230 | 0 to 640.2 K |
Dec 08 2014 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Option Exercise | X | 0.76 | 11,502 | 8,742 | 0 | |
Dec 08 2014 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Option Exercise | C | 0.00 | 492,618 | 0 | 0 | |
Dec 08 2014 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Option Exercise | C | 0.00 | 747,000 | 0 | 0 | |
Dec 08 2014 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Sell | J | 0.00 | 17,383 | 0 | 1,917,107 | 1.9 M to 1.9 M (-0.90 %) |
Dec 08 2014 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Buy | P | 11.00 | 394,918 | 4,344,098 | 1,934,490 | 1.5 M to 1.9 M (+25.65 %) |
Dec 08 2014 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Sell | S | 11.00 | 792 | 8,712 | 1,539,572 | 1.5 M to 1.5 M (-0.05 %) |
Dec 08 2014 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Buy | X | 0.76 | 11,502 | 8,742 | 1,540,364 | 1.5 M to 1.5 M (+0.75 %) |